Eisai Pharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 318.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 270.83 Cr
as on 23-10-2024
- Company Age 17 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 17.54%
(FY 2023)
- Profit 44.39%
(FY 2023)
- Ebitda 38.57%
(FY 2023)
- Net Worth 4.96%
(FY 2023)
- Total Assets -3.03%
(FY 2023)
About Eisai Pharmaceuticals India
The Corporate was formerly known as Eisai Pharmatechnology & Manufacturing Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 318.00 Cr and a paid-up capital of Rs 270.83 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Eisai Pharmaceuticals India Private Limited India is Siddhartha Londhe as COMPANY SECRETARY. Kyo Toda, Kentaro Nagane, Akio Kayano, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24232AP2007PTC053247
- Company No.
053247
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Mar 2007
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Eisai Pharmaceuticals India Private Limited offer?
Eisai Pharmaceuticals India Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, API Intermediate, Common Disease Medicines, Anti Smoking Drugs, Digestive System API, Respiratory System Drugs, Anti Asthma Drug, Pain Relief Drugs & Pharmaceuticals, Muscle Relaxant, TB, Tumor & Cancer Drugs.
Who are the key members and board of directors at Eisai Pharmaceuticals India?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Siddhartha Londhe | Company Secretary | 30-Sep-2024 | Current |
Kyo Toda  | Managing Director | 18-Apr-2024 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kentaro Nagane | Director | 18-Apr-2024 | Current |
| Akio Kayano | Director | 18-Apr-2024 | Current |
| Mitsuru Shomon | Director | 16-Sep-2021 | Current |
| Kazuhiko Tamura | Director | 28-Jul-2021 | Current |
| Shohei Kanazawa | Director | 25-Jun-2020 | Current |
Girish Dixit  | Director | 24-Oct-2019 | Current |
Financial Performance of Eisai Pharmaceuticals India.
Eisai Pharmaceuticals India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.54% increase. The company also saw a substantial improvement in profitability, with a 44.39% increase in profit. The company's net worth moved up by a moderate rise of 4.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eisai Pharmaceuticals India?
In 2022, Eisai Pharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eisai Pharmaceuticals India?
Eisai Pharmaceuticals India has a workforce of 541 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eisai Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eisai Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
